Acquired Thrombocytopenia in Contemporary Transcatheter Aortic Valve Prosthesis

Abstract

Background Postprocedural thrombocytopenia is a known phenomenon following transcatheter aortic valve implantation (TAVI). The aim of this study is to evaluate whether postinterventional platelet kinetics differ when comparing the current generation of balloon-expandable valve (BEV) and self-expanding valve (SEV) prostheses.

Methods We performed a retrospective analysis of patients undergoing TAVI at our facility between 2017 and 2019. Patients were stratified according to the type of prosthesis used: BEV or SEV. Hematocrit-corrected platelet counts were calculated to account for dilution. Nadir platelet counts (lowest recorded platelet count), drop platelet counts (DPC; highest relative platelet drop from baseline), and severity of thrombocytopenia during the discourse and at discharge were assessed.

Results Of the 277 included patients, 212 received SEV and 65 BEV. BEV patients were younger (81.8 ± 4.4 years vs 79.7 ± 6.8 years, p = 0.03). Further demographic characteristics were similar between groups. Implanted SEV were larger (p < 0.001) and had shorter procedural times (p < 0.01). There were no significant differences in postprocedural discourse. Postinterventional platelet drop was more pronounced in BEV patients in several evaluated metrics: mean DPC (24.3 ± 10.9% vs 18.8 ± 14.8%, p < 0.01), patients with DPC > 30% (n = 19, 29.2%, vs n = 33, 15.6%, p = 0.02), and also when comparing platelet kinetics.

Conclusion Despite improvements in outcome, the current generation of balloon-expandable TAVI prostheses carries a predisposition for postprocedural thrombocytopenia even when the effects of dilution are accounted for.

Keywords

aortic valve and root - heart valve - transapical - percutaneous (TAVI) - surgery - complications

Data Availability Statement

The data underlying this article will be shared on reasonable request to the corresponding author.

Publication History

Received: 05 June 2023

Accepted: 14 October 2023

Accepted Manuscript online:
25 October 2023

Article published online:
18 December 2023

• References

• 1 Cribier A, Eltchaninoff H, Bash A. et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106 (24) 3006-3008
• 2 Vahanian A, Beyersdorf F, Praz F. et al; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022; 43 (07) 561-632
• 3 Mack MJ, Leon MB, Thourani VH. et al; PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019; 380 (18) 1695-1705
• 4 Goel S, Pasam RT, Wats K. et al. Transcatheter aortic valve replacement versus surgical aortic valve replacement in low-surgical-risk patients: an updated meta-analysis. Catheter Cardiovasc Interv 2020; 96 (01) 169-178
• 5 Gallet R, Seemann A, Yamamoto M. et al. Effect of transcatheter (via femoral artery) aortic valve implantation on the platelet count and its consequences. Am J Cardiol 2013; 111 (11) 1619-1624
• 6 Abu Khadija H, Gandelman G, Ayyad O. et al. Trends in transfemoral aortic valve implantation related thrombocytopenia. J Clin Med 2022; 11 (03) 11
• 7 Dvir D, Généreux P, Barbash IM. et al. Acquired thrombocytopenia after transcatheter aortic valve replacement: clinical correlates and association with outcomes. Eur Heart J 2014; 35 (38) 2663-2671
• 8 Jiritano F, Santarpino G, Serraino GF. et al. Peri-procedural thrombocytopenia after aortic bioprosthesis implant: a systematic review and meta-analysis comparison among conventional, stentless, rapid-deployment, and transcatheter valves. Int J Cardiol 2019; 296: 43-50
• 9 Hernández-Enríquez M, Chollet T, Bataille V. et al. Comparison of the frequency of thrombocytopenia after transfemoral transcatheter aortic valve implantation between balloon-expandable and self-expanding valves. Am J Cardiol 2019; 123 (07) 1120-1126
• 10 Sinning J-M, Scheer A-C, Adenauer V. et al. Systemic inflammatory response syndrome predicts increased mortality in patients after transcatheter aortic valve implantation. Eur Heart J 2012; 33 (12) 1459-1468
• 11 Mitrosz M, Chlabicz M, Hapaniuk K. et al. Thrombocytopenia associated with TAVI-the summary of possible causes. Adv Med Sci 2017; 62 (02) 378-382
• 12 Morello A, Corcione N, Ferraro P. et al. The best way to transcatheter aortic valve implantation: from standard to new approaches. Int J Cardiol 2021; 322: 86-94
• 13 Nakamura M, Chakravarty T, Jilaihawi H. et al. Complete percutaneous approach for arterial access in transfemoral transcatheter aortic valve replacement: a comparison with surgical cut-down and closure. Catheter Cardiovasc Interv 2014; 84 (02) 293-300
• 14 De Labriolle A, Bonello L, Lemesle G. et al. Decline in platelet count in patients treated by percutaneous coronary intervention: definition, incidence, prognostic importance, and predictive factors. Eur Heart J 2010; 31 (09) 1079-1087
• 15 Sexton T, Alkhasova M, de Beer M, Lynch D, Smyth S. Changes in thromboinflammatory profiles across the generations of transcatheter aortic heart valves. J Thromb Thrombolysis 2019; 47 (02) 174-178
• 16 Kisacik H, Tok D, Balci KG. et al. Evaluation of acquired thrombocytopenia according to the balloon-expandable versus self-expandable valves in patients undergoing transcatheter aortic valve replacement. Angiology 2021; 72 (03) 290-294
• 17 Corcione N, Romano S, Morello A. et al. Thrombocytopenia complicating transcatheter aortic valve implantation: differences between two new-generation devices. J Cardiovasc Transl Res 2021; 14 (06) 1104-1113
• 18 Krumsdorf U, Chorianopoulos E, Pleger ST. et al. C-reactive protein kinetics and its prognostic value after transfemoral aortic valve implantation. J Invasive Cardiol 2012; 24 (06) 282-286
• 19 Rowley JW, Finn AV, French PA. et al; 2011 Platelet Colloquium Participants. Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses. Circ Cardiovasc Interv 2012; 5 (02) 296-304
• 20 Yamada Y, Miura D, Takamori A, Nogami E, Yunoki J, Sakaguchi Y. Predictors of short-term thrombocytopenia after transcatheter aortic valve implantation: a retrospective study at a single Japanese center. BMC Res Notes 2020; 13 (01) 536